Trial Profile
A retrospective study of mirabegron in patients with lower urinary tract dysfunction with low-compliance bladder
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Sep 2016
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary)
- Indications Lower urinary tract symptoms; Overactive bladder
- Focus Therapeutic Use
- 16 Sep 2016 New trial record